Daily Profit
The Next SalesForce Pre-IPO for 620% Gains
SalesForce (NYSE: CRM) just scored another +$1 billion gain . . . By purchasing Pre-IPO shares of Snowflake (NYSE: SNOW). Shares of Snowflake have surged 126% since its September… Read more
George Soros HATES This Stock After Making $175 Million
George Soros is one of the world’s best hedge fund managers. Back in 2012, his investment fund bought private Pre-IPO shares of Palantir (NYSE: PLTR). Palantir was valued at… Read more
Dr. Fauci Says Cancel Thanksgiving
The United States passed a grim milestone yesterday: 250,000 deaths from Covid-19. Our immediate future looks just as dark. The U.S. reported 163,075 coronavirus cases on Wednesday, pushing the… Read more
Can Robots STOP the Virus?
Scientists have worried that Covid-19 immunity may not be long lasting, but a new study delivers some good news. Researchers from the La Jolla Institute for Immunology looked at… Read more
Warren Buffett Reveals Top Biotech Stocks to Buy Now
The origin of Covid-19 remains a scientific mystery. The consensus had been that it likely originated somewhere near Wuhan, China. But it now looks like that was wrong. The… Read more
S&P 500 Approves Tesla Motors – Stock Adds $43 Billion
Tesla Motors (NASDAQ: TSLA) stock is soaring 11%! Today’s move adds $43 billion in market value for the world’s #1 electric vehicle stock. America’s biggest stock market index has… Read more
Is THIS the Vaccine to Stop Covid?
A new vaccine may be the most effective to fight the coronavirus. Moderna (NASDAQ: MRNA) just announced initial results from vaccine. The Moderna vaccine is 94.5% effective in protecting… Read more
Pfizer Versus Moderna: Who Has the Best Vaccine
There is more excellent news on Covid vaccines today: Moderna (NASDAQ: MRNA) said its Covid-19 vaccine had shown 94.5% efficacy in clinical trials. The company’s CEO, Stéphane Bancel, said… Read more
Investment Advice from the Federal Reserve Bank
Mental health is emerging as a major concern as Covid-19 spreads through the population. The latest worry came from a study a study published in The Lancet Psychiatry journal…. Read more